Pancreatic Cancer Research

ResearcherNational Taiwan UniversityNo recent work listed

Yulin Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5574-7062; OpenAlex author ID A5081210398. Sources: ClinicalTrials.gov.

Their work

Papers
4 (first author 1, last author 0)
Trials
2 (principal investigator on 2)
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2009: 2 trials · 2010: none · 2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 4

  1. A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma-TCOG T1211 study. Co-author DOI 10.1016/j.ejca.2019.10.023↗
  2. Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. Co-author DOI 10.1016/s1470-2045(13)70388-7↗
  3. CXCR4 expression predicts early liver recurrence and poor survival after resection of pancreatic adenocarcinoma. Co-author DOI 10.1038/ctg.2012.18↗
  4. Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced… First author DOI 10.1016/j.ijrobp.2010.10.034↗

Trials 2

  1. Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer Principal investigator NCT00813163↗
  2. A Phase III Study of Pancreatic Cancer Principal investigator NCT00994721↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jen‐Shi Chen · 2 shared papers, 2011–2020 · strength 0.13
  2. Li‐Tzong Chen · 2 shared papers, 2011–2020 · strength 0.13
  3. Yan‐Shen Shan · 2 shared papers, 2011–2020 · strength 0.13
  4. Nai‐Jung Chiang · 1 shared paper, 2020 · strength 0.11
  5. Chiun Hsu · 1 shared paper, 2020 · strength 0.11
  6. Kelvin K. Tsai · 1 shared paper, 2020 · strength 0.11
  7. Shih‐Hung Yang · 1 shared paper, 2020 · strength 0.11
  8. Yu‐Wen Tien · 2 shared papers, 1 shared trial, 2009–2012 · strength 0.09
  9. Jaw‐Town Lin · 2 shared papers, 2012–2013 · strength 0.07
  10. Wei‐Chih Liao · 2 shared papers, 2012–2013 · strength 0.07
  11. Pin-Wen Lin · 1 shared paper, 1 shared trial, 2009–2011 · strength 0.06
  12. Tsann‐Long Hwang · 1 shared paper, 1 shared trial, 2009–2011 · strength 0.06
  13. Andrew H. Ko · 1 shared trial, 2009 · strength 0.05
  14. Li-Tzong Chen · 1 shared trial, 2009 · strength 0.05
  15. Yu‐Kang Tu · 1 shared paper, 2013 · strength 0.04
  16. Kuo‐Liong Chien · 1 shared paper, 2013 · strength 0.04
  17. Yi‐Ming Shyr · 1 shared trial, 2009 · strength 0.04
  18. Hsin‐Yi Huang · 1 shared paper, 2012 · strength 0.03
  19. Yen‐Feng Chiu · 1 shared paper, 2011 · strength 0.02
  20. Ann‐Lii Cheng · 1 shared paper, 2011 · strength 0.02
  21. Chih‐Hung Hsu · 1 shared paper, 2011 · strength 0.02
  22. Ming‐Chu Chang · 1 shared paper, 2011 · strength 0.02
  23. Hui-Ju Ch’ang · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.